Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.7968
-0.0053 (-0.66%)
Mar 18, 2026, 9:57 AM EDT - Market open
Dyadic International Employees
Dyadic International had 6 employees as of December 31, 2024. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$557,033
Profits / Employee
-$1,224,708
Market Cap
28.83M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2021 | 7 | 1 | 16.67% |
| Dec 31, 2020 | 6 | 0 | - |
| Dec 31, 2019 | 6 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| Barinthus Biotherapeutics | 105 |
| IGC Pharma | 70 |
| Xilio Therapeutics | 64 |
| Cue Biopharma | 41 |
| Tempest Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| Hyperion DeFi | 14 |
DYAI News
- 2 days ago - Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewsWire
- 6 days ago - Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - GlobeNewsWire
- 14 days ago - Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) - GlobeNewsWire
- 16 days ago - Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone - GlobeNewsWire
- 4 weeks ago - Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin - GlobeNewsWire
- 3 months ago - Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins - GlobeNewsWire
- 3 months ago - Dyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript - Seeking Alpha
- 3 months ago - Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets - GlobeNewsWire